PBLA - Panbela Therapeutics announces delay of expected data from pancreatic cancer treatment trial
2024-04-22 09:18:37 ET
More on Panbela Therapeutics
- Panbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call Transcript
- Panbela Therapeutics closes ~$9M public offering of shares
- Panbela Therapeutics drops on $9M public offering
- Seeking Alpha’s Quant Rating on Panbela Therapeutics
- Historical earnings data for Panbela Therapeutics